Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2009
-
By Donald Zuhn — Affordable Health Care for America Act Placed on Senate Legislative Calendar The Affordable Health Care for America Act (H.R. 3962), which was passed by the House of Representatives on November 7th by a narrow five-vote margin (220-215), has now been placed on the Senate Legislative Calendar. The 1,990-page bill includes…
-
By Kevin E. Noonan — In Anna Karenina, Leo Tolstoy wrote, "All happy families resemble one another, each unhappy family is unhappy in its own way." This sentiment could also be applied to the briefs submitted to the Federal Circuit for its en banc consideration of the written description requirement. A large proportion of…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Daiichi Sankyo Co. Ltd. et al. v. Sandoz Inc.1:09-cv-00898; filed November 25, 2009 in the District Court of Delaware • Plaintiffs: Daiichi Sankyo…
-
December 7, 2009 – 20th Annual Conference on U.S. Patent and Trademark Office Law and Practice (PTO Day) (Intellectual Property Owners Association (IPO) and U.S. Patent and Trademark Office) – Washington, DC December 7-8, 2009 – Foreign Patent Law & Regulation*** (American Conference Institute) – New York, NY December 9, 2010 – Biotechnology/Chemical/Pharmaceutical (BCP) Customer…
-
The next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting will be held on December 9, 2009. The proposed agenda for that meeting is as follows: Morning Session • Greetings and Overview (10:00 – 10:15 am EDT): John LeGuyader and Remy Yucel, Directors, Technology Center 1600 • Count System Changes (10:15 – 11:15 am): Bruce Kisliuk, Assistant Deputy…
-
American Conference Institute (ACI) will be holding its 7th National Conference on Life Sciences IP Due Diligence from January 20-21, 2010 in New York. The conference will allow attendees to: • Incorporate the impact of patent reform and new regulations on follow-on biologics into an IP due diligence review protocol;• Evaluate the breadth, strength and…
-
American Conference Institute (ACI) will be holding its European Pharmaceutical Regulatory Law Boot Camp from January 25-26, 2010 in New York. The conference will allow attendees to: • Master the essentials of the different modes of the European drug approval process, including Centralized Procedure through the European Medicines Agency (the EMEA);• Understand the role of…
-
By Christopher P. Singer — In the spirit of the Thanksgiving holiday, we take a closer look at U.S. Patent No. 6,708,440, entitled "Turkey Decoy" (which is admittedly outside our usual biotech/pharma focus). The '440 patent addresses a problem that has long-plagued the turkey hunting arts, specifically that prior turkey decoys were not laterally…
-
By Kevin E. Noonan — The Intellectual Property Owners Association (IPO) has filed an amicus brief in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., supporting neither party but arguing in favor of a separate written description requirement as part of 35 U.S.C. § 112, first paragraph. The IPO's…
-
By Suresh Pillai — Exela Files Appeal to Alphagan® Decision Following a ruling by the U.S. District Court for the District of Delaware that Exela PharmSci's proposed generic version of Allergan's Alphagan® glaucoma treatment infringed an Allergan patent, Exela has filed a notice of appeal, seeking to have the District Court's decision reviewed by…
Patent Docs 